1. LUNG CANCER SCREENING & SMOKING CESSATION

2. Acknowledgements

3. Objectives

5. Is it cost-effective?

6. Cost-Effectiveness Ratios

7. How do the CRMM results compare to other results?

8. How does the CRMM compare?

9. What does this mean for you?

10. How many people would be eligible?

13. What if the smoking cessation program was super expensive?

15. Conclusions

16. Limitations

17. Additional work

19. APPENDIX

20. What is the Cancer Risk Management Model (CRMM)?

21. Who is Leading the CRM?

22. Publications

24. Changes since the last presentation to the Network:

25. Number of new lung cancer cases by trial arm by year of study from Model and NLST

26. Lung Cancer Mortality Reduction

30. Insert jurisdictional cost slides

31. Over-diagnosis